Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

A nanoparticle formulation that selectively transfects metastatic tumors in mice.

Yang J, Hendricks W, Liu G, McCaffery JM, Kinzler KW, Huso DL, Vogelstein B, Zhou S.

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14717-22. doi: 10.1073/pnas.1313330110. Epub 2013 Aug 19.

2.

Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.

Yang F, Gou M, Deng H, Yi T, Zhong Q, Wei Y, Zhao X.

Oncol Rep. 2012 Aug;28(2):668-76. doi: 10.3892/or.2012.1853. Epub 2012 Jun 6.

PMID:
22684947
3.

Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A.

Zhang L, Gao X, Men K, Wang B, Zhang S, Qiu J, Huang M, Gou M, Huang N, Qian Z, Zhao X, Wei Y.

Int J Nanomedicine. 2011;6:2419-27. doi: 10.2147/IJN.S23582. Epub 2011 Oct 19.

4.

Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.

Klutz K, Willhauck MJ, Dohmen C, Wunderlich N, Knoop K, Zach C, Senekowitsch-Schmidtke R, Gildehaus FJ, Ziegler S, Fürst S, Göke B, Wagner E, Ogris M, Spitzweg C.

Hum Gene Ther. 2011 Dec;22(12):1563-74. doi: 10.1089/hum.2011.041. Epub 2011 Oct 11.

5.

Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.

Yang XZ, Dou S, Sun TM, Mao CQ, Wang HX, Wang J.

J Control Release. 2011 Dec 10;156(2):203-11. doi: 10.1016/j.jconrel.2011.07.035. Epub 2011 Aug 1.

PMID:
21839126
6.

Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.

Liu P, Gou M, Yi T, Xie C, Qi X, Zhou S, Deng H, Wei Y, Zhao X.

Oncol Rep. 2012 Feb;27(2):363-70. doi: 10.3892/or.2011.1550. Epub 2011 Nov 11.

PMID:
22086394
7.

Theranostic nanoparticles based on bioreducible polyethylenimine-coated iron oxide for reduction-responsive gene delivery and magnetic resonance imaging.

Li D, Tang X, Pulli B, Lin C, Zhao P, Cheng J, Lv Z, Yuan X, Luo Q, Cai H, Ye M.

Int J Nanomedicine. 2014 Jul 10;9:3347-61. doi: 10.2147/IJN.S61463. eCollection 2014.

8.

Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.

Hu YL, Huang B, Zhang TY, Miao PH, Tang GP, Tabata Y, Gao JQ.

Mol Pharm. 2012 Sep 4;9(9):2698-709. doi: 10.1021/mp300254s. Epub 2012 Aug 15.

PMID:
22862421
9.

Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model.

Schädlich A, Caysa H, Mueller T, Tenambergen F, Rose C, Göpferich A, Kuntsche J, Mäder K.

ACS Nano. 2011 Nov 22;5(11):8710-20. doi: 10.1021/nn2026353. Epub 2011 Oct 10.

PMID:
21970766
10.

[Effect of nanosize delivery system for ASODN against hTERT on the expression of telomerase in the esophageal cancer EC9706 cells].

Wang J, Zhang ZZ, Zhou TY, Liu YQ, Li HX.

Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):566-72. Chinese.

PMID:
19102931
11.

T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.

Kuang Y, An S, Guo Y, Huang S, Shao K, Liu Y, Li J, Ma H, Jiang C.

Int J Pharm. 2013 Sep 15;454(1):11-20. doi: 10.1016/j.ijpharm.2013.07.019. Epub 2013 Jul 15.

PMID:
23867728
12.

Adenoviral vectors modified by heparin-polyethyleneimine nanogels enhance targeting to the lung and show therapeutic potential for pulmonary metastasis in vivo.

Wei W, Mu Y, Li X, Gou M, Zhang H, Luo S, Men K, Mao Y, Qian Z, Yang L.

J Biomed Nanotechnol. 2011 Dec;7(6):768-75.

PMID:
22416575
13.

Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.

Shahzad MM, Mangala LS, Han HD, Lu C, Bottsford-Miller J, Nishimura M, Mora EM, Lee JW, Stone RL, Pecot CV, Thanapprapasr D, Roh JW, Gaur P, Nair MP, Park YY, Sabnis N, Deavers MT, Lee JS, Ellis LM, Lopez-Berestein G, McConathy WJ, Prokai L, Lacko AG, Sood AK.

Neoplasia. 2011 Apr;13(4):309-19.

14.

Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation.

Hu S, Zhang Y.

Int J Nanomedicine. 2010 Nov 24;5:1039-48. doi: 10.2147/IJN.S14753.

15.

Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles.

Shen J, Sun H, Xu P, Yin Q, Zhang Z, Wang S, Yu H, Li Y.

Biomaterials. 2013 Feb;34(5):1581-90. doi: 10.1016/j.biomaterials.2012.10.057. Epub 2012 Nov 9.

PMID:
23146437
16.

Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy.

Sharma B, Peetla C, Adjei IM, Labhasetwar V.

Cancer Lett. 2013 Jul 1;334(2):228-36. doi: 10.1016/j.canlet.2013.03.011. Epub 2013 Mar 21.

17.

RPM peptide conjugated bioreducible polyethylenimine targeting invasive colon cancer.

Lee YM, Lee D, Kim J, Park H, Kim WJ.

J Control Release. 2015 May 10;205:172-80. doi: 10.1016/j.jconrel.2015.01.020. Epub 2015 Jan 21.

PMID:
25616161
18.

A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.

Ding Y, Wang W, Feng M, Wang Y, Zhou J, Ding X, Zhou X, Liu C, Wang R, Zhang Q.

Biomaterials. 2012 Dec;33(34):8893-905. doi: 10.1016/j.biomaterials.2012.08.057. Epub 2012 Sep 12.

PMID:
22979990
19.

Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.

Hine CM, Seluanov A, Gorbunova V.

Mol Ther. 2012 Feb;20(2):347-55. doi: 10.1038/mt.2011.215. Epub 2011 Oct 18.

20.

Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.

He XW, Liu T, Chen YX, Cheng DJ, Li XR, Xiao Y, Feng YL.

Cancer Gene Ther. 2008 Mar;15(3):193-202. doi: 10.1038/sj.cgt.7701122. Epub 2008 Jan 18.

PMID:
18202713
Items per page

Supplemental Content

Write to the Help Desk